CJC-1295 with DAC is a long-acting analogue of growth hormone-releasing hormone (GHRH).

The DAC modification extends its activity, making it a subject of research into growth hormone signalling and downstream IGF-1 responses.

Commonly researched areas of interest

• Growth hormone-releasing hormone signalling

• Pituitary growth hormone response

• Insulin-like growth factor I pathways

• Albumin binding and peptide persistence

• Endocrine feedback mechanisms

• Long-acting peptide pharmacology

Small controlled human studies have reported sustained growth hormone and IGF-I responses. These findings do not establish muscle-building, anti-ageing or general wellness benefits for this product.

For research use only. Not for human consumption.